NBIX logo

Neurocrine Biosciences (NBIX) Working capital

annual working capital:

$1.22B+$264.80M(+27.81%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual working capital is $1.22 billion, with the most recent change of +$264.80 million (+27.81%) on December 31, 2024.
  • During the last 3 years, NBIX annual working capital has risen by +$490.00 million (+67.40%).
  • NBIX annual working capital is now at all-time high.

Performance

NBIX Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

quarterly working capital:

$1.11B-$102.00M(-8.38%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly working capital is $1.11 billion, with the most recent change of -$102.00 million (-8.38%) on March 31, 2025.
  • Over the past year, NBIX quarterly working capital has increased by +$28.90 million (+2.66%).
  • NBIX quarterly working capital is now -22.94% below its all-time high of $1.45 billion, reached on September 30, 2024.

Performance

NBIX quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

NBIX Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+27.8%+2.7%
3 y3 years+67.4%+45.8%
5 y5 years+358.0%+34.7%

NBIX Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+67.4%-22.9%+54.8%
5 y5-yearat high+358.0%-22.9%+104.3%
alltimeall timeat high+3335.3%-22.9%+5269.1%

NBIX Working capital History

DateAnnualQuarterly
Mar 2025
-
$1.11B(-8.4%)
Dec 2024
$1.22B(+27.8%)
$1.22B(-15.9%)
Sep 2024
-
$1.45B(+13.8%)
Jun 2024
-
$1.27B(+17.1%)
Mar 2024
-
$1.09B(+14.1%)
Dec 2023
$952.20M(+4.0%)
$952.20M(-0.6%)
Sep 2023
-
$958.30M(+4.8%)
Jun 2023
-
$914.10M(-13.7%)
Mar 2023
-
$1.06B(+15.6%)
Dec 2022
$915.80M(+26.0%)
$915.80M(+27.1%)
Sep 2022
-
$720.40M(-1.8%)
Jun 2022
-
$733.60M(-4.1%)
Mar 2022
-
$764.70M(+5.2%)
Dec 2021
$727.00M(-12.4%)
$727.00M(-6.8%)
Sep 2021
-
$779.80M(-13.1%)
Jun 2021
-
$897.20M(+0.2%)
Mar 2021
-
$895.40M(+7.9%)
Dec 2020
$829.70M(+212.3%)
$829.70M(+52.0%)
Sep 2020
-
$545.90M(-4.8%)
Jun 2020
-
$573.20M(-30.8%)
Mar 2020
-
$827.90M(+211.6%)
Dec 2019
$265.70M(-59.1%)
$265.70M(-62.2%)
Sep 2019
-
$703.58M(+8.5%)
Jun 2019
-
$648.22M(+15.5%)
Mar 2019
-
$561.19M(-13.6%)
Dec 2018
$649.54M(+29.8%)
$649.54M(+151.8%)
Sep 2018
-
$257.99M(-49.0%)
Jun 2018
-
$505.92M(+8.3%)
Mar 2018
-
$467.25M(-6.6%)
Dec 2017
$500.49M(+78.7%)
$500.49M(-1.9%)
Sep 2017
-
$510.34M(+0.3%)
Jun 2017
-
$509.03M(+135.8%)
Mar 2017
-
$215.89M(-22.9%)
Dec 2016
$280.03M(-21.9%)
$280.03M(-15.5%)
Sep 2016
-
$331.23M(-9.3%)
Jun 2016
-
$365.07M(-3.3%)
Mar 2016
-
$377.71M(+5.4%)
Dec 2015
$358.36M(+96.3%)
$358.36M(-1.3%)
Sep 2015
-
$362.96M(-2.4%)
Jun 2015
-
$371.86M(-4.6%)
Mar 2015
-
$389.77M(+113.5%)
Dec 2014
$182.54M(+33.5%)
$182.54M(+7.5%)
Sep 2014
-
$169.82M(-8.5%)
Jun 2014
-
$185.52M(-12.1%)
Mar 2014
-
$211.13M(+54.4%)
Dec 2013
$136.76M(-21.2%)
$136.76M(-6.3%)
Sep 2013
-
$145.90M(+3.3%)
Jun 2013
-
$141.28M(-3.6%)
Mar 2013
-
$146.52M(-15.6%)
Dec 2012
$173.62M(+103.4%)
$173.62M(+12.1%)
Sep 2012
-
$154.91M(+1.8%)
Jun 2012
-
$152.11M(+2.5%)
Mar 2012
-
$148.34M(+73.8%)
Dec 2011
$85.37M(+6.3%)
$85.37M(-2.6%)
Sep 2011
-
$87.68M(+25.2%)
Jun 2011
-
$70.05M(-9.7%)
Mar 2011
-
$77.56M(-3.4%)
Dec 2010
$80.27M
$80.27M(+2.4%)
DateAnnualQuarterly
Sep 2010
-
$78.41M(-14.4%)
Jun 2010
-
$91.64M(+84.4%)
Mar 2010
-
$49.70M(+40.3%)
Dec 2009
$35.43M(-36.0%)
$35.43M(+3.7%)
Sep 2009
-
$34.15M(+64.4%)
Jun 2009
-
$20.77M(-40.1%)
Mar 2009
-
$34.67M(-37.3%)
Dec 2008
$55.33M(-63.8%)
$55.33M(-30.7%)
Sep 2008
-
$79.83M(-15.2%)
Jun 2008
-
$94.14M(-29.9%)
Mar 2008
-
$134.23M(-12.3%)
Dec 2007
$153.04M(-11.8%)
$153.04M(+41.5%)
Sep 2007
-
$108.16M(-17.8%)
Jun 2007
-
$131.65M(-13.7%)
Mar 2007
-
$152.49M(-12.1%)
Dec 2006
$173.54M(-29.3%)
$173.54M(-5.4%)
Sep 2006
-
$183.51M(-15.3%)
Jun 2006
-
$216.69M(-10.4%)
Mar 2006
-
$241.97M(-1.5%)
Dec 2005
$245.62M(-3.4%)
$245.62M(-6.5%)
Sep 2005
-
$262.59M(+13.6%)
Jun 2005
-
$231.23M(-1.1%)
Mar 2005
-
$233.85M(-8.0%)
Dec 2004
$254.23M(-29.7%)
$254.23M(-3.9%)
Sep 2004
-
$264.55M(-1.5%)
Jun 2004
-
$268.55M(-5.5%)
Mar 2004
-
$284.11M(-21.5%)
Dec 2003
$361.80M(+67.8%)
$361.80M(+3.6%)
Sep 2003
-
$349.10M(+64.1%)
Jun 2003
-
$212.69M(-13.1%)
Mar 2003
-
$244.72M(+13.5%)
Dec 2002
$215.62M(-29.7%)
$215.62M(-14.3%)
Sep 2002
-
$251.51M(-7.2%)
Jun 2002
-
$270.97M(-6.5%)
Mar 2002
-
$289.95M(-5.5%)
Dec 2001
$306.75M(+94.8%)
$306.75M(+118.7%)
Sep 2001
-
$140.26M(+3.1%)
Jun 2001
-
$135.99M(-7.4%)
Mar 2001
-
$146.79M(-6.8%)
Dec 2000
$157.45M(+82.7%)
$157.45M(+117.9%)
Sep 2000
-
$72.24M(-5.0%)
Jun 2000
-
$76.03M(-7.4%)
Mar 2000
-
$82.09M(-4.8%)
Dec 1999
$86.20M(+43.7%)
$86.20M(+75.2%)
Sep 1999
-
$49.20M(-6.8%)
Jun 1999
-
$52.80M(-6.9%)
Mar 1999
-
$56.70M(-5.5%)
Dec 1998
$60.00M(-13.5%)
$60.00M(-4.5%)
Sep 1998
-
$62.80M(-0.5%)
Jun 1998
-
$63.10M(-7.6%)
Mar 1998
-
$68.30M(-1.6%)
Dec 1997
$69.40M(+2.1%)
$69.40M(+1.8%)
Sep 1997
-
$68.20M(+1.6%)
Jun 1997
-
$67.10M(-6.5%)
Mar 1997
-
$71.80M(+5.6%)
Dec 1996
$68.00M
$68.00M(+6.9%)
Sep 1996
-
$63.60M(-2.2%)
Jun 1996
-
$65.00M(+199.5%)
Mar 1996
-
$21.70M

FAQ

  • What is Neurocrine Biosciences annual working capital?
  • What is the all time high annual working capital for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual working capital year-on-year change?
  • What is Neurocrine Biosciences quarterly working capital?
  • What is the all time high quarterly working capital for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly working capital year-on-year change?

What is Neurocrine Biosciences annual working capital?

The current annual working capital of NBIX is $1.22B

What is the all time high annual working capital for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual working capital is $1.22B

What is Neurocrine Biosciences annual working capital year-on-year change?

Over the past year, NBIX annual working capital has changed by +$264.80M (+27.81%)

What is Neurocrine Biosciences quarterly working capital?

The current quarterly working capital of NBIX is $1.11B

What is the all time high quarterly working capital for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly working capital is $1.45B

What is Neurocrine Biosciences quarterly working capital year-on-year change?

Over the past year, NBIX quarterly working capital has changed by +$28.90M (+2.66%)
On this page